tiprankstipranks
Trending News
More News >
Global Health Limited (IN:MEDANTA)
:MEDANTA
India Market
Advertisement

Global Health Limited (MEDANTA) Stock Forecast & Price Target

Compare
0 Followers
See the Price Targets and Ratings of:

MEDANTA Analyst Ratings

Moderate Buy
5Ratings
Moderate Buy
3 Buy
1 Hold
1 Sell
Based on 5 analysts giving stock ratings to
Global
Health Limited
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

MEDANTA Stock 12 Month Forecast

Average Price Target

₹1,453.60
▲(3.82% Upside)
Based on 5 Wall Street analysts offering 12 month price targets for Global Health Limited in the last 3 months. The average price target is ₹1,453.60 with a high forecast of ₹1,598.00 and a low forecast of ₹1,200.00. The average price target represents a 3.82% change from the last price of ₹1,400.05.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"999":"₹999","1149":"₹1,149","1299":"₹1,299","1449":"₹1,449","1599":"₹1,599"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":1598,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">₹1.60K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1453.6,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">₹1.45K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1200,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">₹1.20K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[999,1149,1299,1449,1599],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jul<br/>2024","6":"Oct<br/>2024","9":"Dec<br/>2024","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1337.47,1357.5107692307693,1377.5515384615385,1397.5923076923077,1417.633076923077,1437.6738461538462,1457.7146153846154,1477.7553846153846,1497.7961538461539,1517.836923076923,1537.8776923076923,1557.9184615384615,1577.9592307692308,{"y":1598,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1337.47,1346.403076923077,1355.3361538461538,1364.2692307692307,1373.2023076923076,1382.1353846153845,1391.0684615384614,1400.0015384615385,1408.9346153846154,1417.8676923076923,1426.8007692307692,1435.7338461538461,1444.666923076923,{"y":1453.6,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1337.47,1326.8953846153847,1316.3207692307692,1305.746153846154,1295.1715384615384,1284.596923076923,1274.0223076923078,1263.4476923076923,1252.873076923077,1242.2984615384617,1231.7238461538461,1221.1492307692308,1210.5746153846153,{"y":1200,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":1329.12,"date":1711929600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1444.38,"date":1714521600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1192.47,"date":1717200000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1270.74,"date":1719792000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1223.46,"date":1722470400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1129.84,"date":1725148800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1000.69,"date":1727740800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1105.2,"date":1730419200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1100.35,"date":1733011200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1100.35,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1042.97,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1150.98,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1337.47,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target₹1,598Average Price Target₹1,454Lowest Price Target₹1,200
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Jefferies Analyst forecast on IN:MEDANTA
Jefferies
Jefferies
₹1,380₹1,530
Buy
9.28%
Upside
Reiterated
08/12/25
Jefferies Sticks to Their Buy Rating for Global Health Limited (MEDANTA)
J.P. Morgan Analyst forecast on IN:MEDANTA
J.P. Morgan
J.P. Morgan
₹1,240₹1,480
Hold
5.71%
Upside
Reiterated
08/11/25
J.P. Morgan Keeps Their Hold Rating on Global Health Limited (MEDANTA)
Kotak Mahindra Analyst forecast on IN:MEDANTA
Kotak Mahindra
Kotak Mahindra
₹1,275₹1,460
Buy
4.28%
Upside
Reiterated
08/11/25
Kotak Mahindra Remains a Buy on Global Health Limited (MEDANTA)Kotak analyst Alankar Garude raised the price target on Global Health Limited (MEDANTA:IN) to INR1,460.00 (from INR1,275.00) while maintaining a Add (2) rating.
HSBC
₹965₹1,200
Sell
-14.29%
Downside
Reiterated
08/11/25
HSBC Reaffirms Their Sell Rating on Global Health Limited (MEDANTA)
TR | OpenAI - 4o Analyst forecast on IN:MEDANTA
TR | OpenAI - 4o
TR | OpenAI - 4o
₹1,499₹1,598
Buy
14.14%
Upside
Reiterated
08/09/25
AI Generated ArticleAI Generated Article
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Jefferies Analyst forecast on IN:MEDANTA
Jefferies
Jefferies
₹1,380₹1,530
Buy
9.28%
Upside
Reiterated
08/12/25
Jefferies Sticks to Their Buy Rating for Global Health Limited (MEDANTA)
J.P. Morgan Analyst forecast on IN:MEDANTA
J.P. Morgan
J.P. Morgan
₹1,240₹1,480
Hold
5.71%
Upside
Reiterated
08/11/25
J.P. Morgan Keeps Their Hold Rating on Global Health Limited (MEDANTA)
Kotak Mahindra Analyst forecast on IN:MEDANTA
Kotak Mahindra
Kotak Mahindra
₹1,275₹1,460
Buy
4.28%
Upside
Reiterated
08/11/25
Kotak Mahindra Remains a Buy on Global Health Limited (MEDANTA)Kotak analyst Alankar Garude raised the price target on Global Health Limited (MEDANTA:IN) to INR1,460.00 (from INR1,275.00) while maintaining a Add (2) rating.
HSBC
₹965₹1,200
Sell
-14.29%
Downside
Reiterated
08/11/25
HSBC Reaffirms Their Sell Rating on Global Health Limited (MEDANTA)
TR | OpenAI - 4o Analyst forecast on IN:MEDANTA
TR | OpenAI - 4o
TR | OpenAI - 4o
₹1,499₹1,598
Buy
14.14%
Upside
Reiterated
08/09/25
AI Generated ArticleAI Generated Article
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Global Health Limited

1 Month
xxx
Success Rate
2/4 ratings generated profit
50%
Average Return
-1.65%
reiterated a xxx
rating 18 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 50.00% of your transactions generating a profit, with an average return of -1.65% per trade.
3 Months
xxx
Success Rate
1/4 ratings generated profit
25%
Average Return
-3.95%
reiterated a xxx
rating 18 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 25.00% of your transactions generating a profit, with an average return of -3.95% per trade.
1 Year
Alok DalalJefferies
Success Rate
3/3 ratings generated profit
Average Return
+11.23%
reiterated a buy rating 17 days ago
Copying Alok Dalal's trades and holding each position for 1 Year would result in - of your transactions generating a profit, with an average return of +11.23% per trade.
2 Years
xxx
Success Rate
1/4 ratings generated profit
25%
Average Return
-9.03%
reiterated a xxx
rating 18 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 25.00% of your transactions generating a profit, with an average return of -9.03% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

MEDANTA Analyst Recommendation Trends

Rating
Dec 24
Feb 25
Jul 25
Aug 25
Strong Buy
0
0
0
0
Buy
1
3
10
11
Hold
0
1
1
2
Sell
0
1
2
3
Strong Sell
0
0
0
0
total
1
5
13
16
In the current month, MEDANTA has received 11 Buy Ratings, 2 Hold Ratings, and 3 Sell Ratings. MEDANTA average Analyst price target in the past 3 months is 1,453.60.
Each month's total comprises the sum of three months' worth of ratings.

MEDANTA Financial Forecast

MEDANTA Earnings Forecast

The previous quarter’s earnings for MEDANTA were ₹5.60.
The previous quarter’s earnings for MEDANTA were ₹5.60.

MEDANTA Sales Forecast

Next quarter’s sales forecast for MEDANTA is ₹10.08B with a range of ₹10.08B to ₹10.08B. The previous quarter’s sales results were ₹10.31B. MEDANTA beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 33.83% of the time in the same period. In the last calendar year MEDANTA has Outperformed its overall industry.
Next quarter’s sales forecast for MEDANTA is ₹10.08B with a range of ₹10.08B to ₹10.08B. The previous quarter’s sales results were ₹10.31B. MEDANTA beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 33.83% of the time in the same period. In the last calendar year MEDANTA has Outperformed its overall industry.

MEDANTA Stock Forecast FAQ

What is IN:MEDANTA’s average 12-month price target, according to analysts?
Based on analyst ratings, Global Health Limited’s 12-month average price target is 1,453.60.
    What is IN:MEDANTA’s upside potential, based on the analysts’ average price target?
    Global Health Limited has 3.82% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Global Health Limited a Buy, Sell or Hold?
          Global Health Limited has a consensus rating of Moderate Buy, which is based on 3 buy ratings, 1 hold ratings and 1 sell ratings.
            What is Global Health Limited’s share price target?
            The average share price target for Global Health Limited is 1,453.60. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is ₹1,598.00 ,and the lowest forecast is ₹1,200.00. The average share price target represents 3.82% Increase from the current price of ₹1,400.05.
              What do analysts say about Global Health Limited?
              Global Health Limited’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 5 Wall Streets Analysts.
                How can I buy shares of Global Health Limited?
                To buy shares of IN:MEDANTA, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis